ArticleInternational journal of clinical oncology2023

Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.

Yixuan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.